Eurofins SAFER@WORKâ„¢ US
BioTech/Drugs - Framingham, MA, US
Eurofins SAFER@WORKâ„¢ US Employees
Eurofins SAFER@WORKâ„¢ US Details
As we look to getting back to work, or continuing business as usual, proactive solutions to contribute to the safety of our staff, our customers and indirectly their families is a top priority for all businesses. The Eurofins SAFER@WORK™ program is designed to help you to set up advanced risk management protocols to contribute to limiting the impact of COVID-19 on your workplace. Eurofins SAFER@WORK™ programs are designed and implemented by our experts and consulting partners, and testing is carried out in Eurofins government licensed clinical laboratories, in compliance with local regulations. By combining workplace surfaces and wastewater testing together with risk-based clinical testing, as well as relevant consultative, audit, and assurance services, Eurofins SAFER@WORK™ programs allow for a focus on human clinical testing where virus presence is likelier. This approach reduces cost and supports health authorities to allocate capacity constrained human COVID-19 testing where it is most needed.
